Published in Gut on May 01, 2005
Occult hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol (2008) 1.90
Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J Virol (2007) 1.47
Occult hepatitis C virus infection: a new form of hepatitis C. World J Gastroenterol (2006) 1.24
New perspectives in occult hepatitis C virus infection. World J Gastroenterol (2012) 1.17
Differential dysfunction in dendritic cell subsets during chronic HCV infection. Clin Immunol (2007) 1.17
The blood transcriptional signature of chronic hepatitis C virus is consistent with an ongoing interferon-mediated antiviral response. J Interferon Cytokine Res (2012) 1.12
Cellular immune responses associated with occult hepatitis C virus infection of the liver. J Virol (2006) 1.02
Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence. Virol J (2011) 0.97
Occult HCV infection: an unexpected finding in a population unselected for hepatic disease. PLoS One (2009) 0.96
Distribution of different hepatitis C virus genotypes in patients with hepatitis C virus infection. World J Gastroenterol (2010) 0.95
Role of miR-122 and lipid metabolism in HCV infection. J Gastroenterol (2012) 0.89
Seronegative hepatitis C virus infection. Arch Immunol Ther Exp (Warsz) (2013) 0.89
CD4+ primary T cells expressing HCV-core protein upregulate Foxp3 and IL-10, suppressing CD4 and CD8 T cells. PLoS One (2014) 0.87
Viral RNA but no evidence of replication can be detected in the peripheral blood mononuclear cells of hepatitis E virus-infected patients. J Viral Hepat (2010) 0.87
Occult hepatitis C virus infection revisited with ultrasensitive real-time PCR assay. J Clin Microbiol (2008) 0.86
Hepatitis C Virus, Insulin Resistance, and Steatosis. J Clin Transl Hepatol (2016) 0.85
Molecular epidemiology of different hepatitis C genotypes in serum and peripheral blood mononuclear cells in jahrom city of iran. Hepat Mon (2014) 0.84
Occult HCV Infection: The Current State of Knowledge. Iran Red Crescent Med J (2015) 0.83
Two distinct functional patterns of hepatitis C Virus (HCV)-specific T cell responses in seronegative, aviremic patients. PLoS One (2013) 0.82
HCV infection and B-cell lymphomagenesis. Adv Hematol (2011) 0.81
Combined hepatitis C virus (HCV) antigen-antibody detection assay does not improve diagnosis for seronegative individuals with occult HCV infection. J Clin Microbiol (2006) 0.81
Prevalence and follow-up of occult HCV infection in an Italian population free of clinically detectable infectious liver disease. PLoS One (2012) 0.81
Serum immunoglobulin G antibodies to the GOR autoepitope are present in patients with occult hepatitis C virus (HCV) infection despite lack of HCV-specific antibodies. Clin Vaccine Immunol (2007) 0.80
Influence of the presence of HCV-RNA in peripheral blood mononuclear cells on the clinical course of chronic hepatitis C in children. Eur J Epidemiol (2007) 0.80
Persistence of hepatitis C virus in peripheral blood mononuclear cells of sustained viral responders to pegylated interferon and ribavirin therapy. Dig Dis Sci (2008) 0.78
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy. Genet Vaccines Ther (2011) 0.78
A New Twist to a Chronic HCV Infection: Occult Hepatitis C. Gastroenterol Res Pract (2015) 0.77
Hepatitis C virus: A time for decisions. Who should be treated and when? World J Gastrointest Pharmacol Ther (2016) 0.76
Platelets can be a biological compartment for the Hepatitis C Virus. Braz J Microbiol (2015) 0.75
Analysis of mutations in the core and NS5A genes of hepatitis C virus in non-responder and relapser patients after treatment with Peg-IFN-α and ribavirin. Virusdisease (2016) 0.75
Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response. Korean J Hepatol (2011) 0.75
Characterization of miR-122-independent propagation of HCV. PLoS Pathog (2017) 0.75
Partial remission of refractory RA after Adacolumn cytapheresis: a case report. Rheumatol Int (2007) 0.75
Avoiding false positives with PCR. Nature (1989) 30.66
Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci U S A (1990) 8.92
Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis (2003) 4.45
Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci U S A (1992) 3.55
Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol (2004) 2.27
Molecular virology of hepatitis C virus. J Gen Virol (1997) 1.71
Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. J Infect Dis (1992) 1.49
Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest (1992) 1.45
Hepatic and extrahepatic hepatitis C virus replication in relation to response to interferon therapy. Hepatology (1994) 1.34
Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection. Hepatology (1996) 1.24
The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus. J Infect Dis (2002) 1.19
Infection of a chimpanzee with hepatitis C virus grown in cell culture. J Gen Virol (1998) 1.13
Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. Transplantation (1998) 1.07
Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA. Liver (1994) 1.02
Presence of hepatitis C virus (HCV) genomic RNA and viral replicative intermediates in bone marrow and peripheral blood mononuclear cells from HCV-infected patients. Clin Diagn Lab Immunol (1994) 0.89
Specific detection of Brucella DNA by PCR. J Clin Microbiol (1995) 2.03
Idiopathic biliary ductopenia in adults without symptoms of liver disease. N Engl J Med (1997) 1.65
Risk factors associated with drug-resistant Mycobacterium tuberculosis in Castilla-la-Mancha (Spain) Eur Respir J (1996) 1.63
The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. J Clin Psychiatry (1999) 1.43
Ribozymes: structure, characteristics and use as potential antiviral agents. J Hepatol (1995) 1.42
Magnetic relaxation of interacting co clusters: crossover from two- to three-dimensional lattices. Phys Rev Lett (2002) 1.40
[Septic pulmonary embolism secondary to a focus of peridental osteitis]. Arch Bronconeumol (1994) 1.39
[Hepatitis C virus and cryoglobulinemia]. Rev Clin Esp (1992) 1.39
Retreatment of chronic hepatitis C virus infection. Lancet (1994) 1.39
Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology (2000) 1.38
Lysosomal stability during phagocytosis of Aspergillus flavus spores by alveolar macrophages of cortisone-treated mice. Science (1968) 1.35
Evaluation of serological tests for diagnosis of Brucella melitensis infection of goats. J Clin Microbiol (1994) 1.31
Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol (1998) 1.31
Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Hepatology (2001) 1.26
The pathogenesis of experimental pulmonary aspergillosis. An ultrastructural study of alveolar macrophages after phagocytosis of a flavus spores in vivo. Am J Pathol (1971) 1.25
Subduction and collision processes in the Central Andes constrained by converted seismic phases. Nature (2001) 1.22
Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology (1999) 1.21
Effect of anti-viral therapy for occult hepatitis C virus infection. Aliment Pharmacol Ther (2006) 1.16
The function of permanent vascular access. Nephrol Dial Transplant (2000) 1.16
Evaluation of PCR and indirect enzyme-linked immunosorbent assay on milk samples for diagnosis of brucellosis in dairy cattle. J Clin Microbiol (1995) 1.13
In situ detection of hepatitis C virus RNA in salivary glands. Am J Pathol (2001) 1.12
Comparative study between occult hepatitis C virus infection and chronic hepatitis C. J Viral Hepat (2007) 1.11
In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus. J Virol (1999) 1.09
Relative quantification and mapping of hepatitis C virus by in situ hybridization and digital image analysis. Hepatology (1998) 1.08
Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol (2001) 1.07
Immunohistochemical localization of a choriogonadotropin-like protein in bacteria isolated from cancer patients. Cancer (1978) 1.07
In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus. J Infect Dis (1999) 1.04
Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff. J Am Soc Nephrol (1997) 1.04
In vitro effect of amantadine and interferon alpha-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients. Antiviral Res (1999) 1.02
Histological damage in chronic hepatitis C is not related to the extent of infection in the liver. Am J Pathol (1999) 1.00
Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users. AIDS (2000) 0.99
Detection of hepatitis C virus replication by In situ hybridization in epithelial cells of anti-hepatitis C virus-positive patients with and without oral lichen planus. Hepatology (2000) 0.99
Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine (1998) 0.99
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B. J Hepatol (2000) 0.97
Insulinlike growth factor I and interleukin 1 beta messenger RNA in a rat model of granulomatous enterocolitis and hepatitis. Gastroenterology (1993) 0.97
High-resolution imaging of remanent state and magnetization reversal of superdomain structures in high-density cobalt antidot arrays. Nanotechnology (2014) 0.97
[Cystic diseases of the lung: high-resolution computed tomography findings]. Arch Bronconeumol (2005) 0.96
Age, sex, and lactating status regulate ghrelin secretion and GOAT mRNA levels from isolated rat stomach. Am J Physiol Endocrinol Metab (2010) 0.96
Analysis of the serologic response to systemic Candida albicans infection in a murine model. Proteomics (2001) 0.95
A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedules. Antiviral Res (1987) 0.95
Semiquantification by Amplicor assay of hepatitis C virus genome during therapy. J Hepatol (1995) 0.95
Electron microscope study on the replication of AAV-1 in herpes-infected cells. Virology (1972) 0.95
Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B. Hepatology (1991) 0.95
Hepatitis E virus seroprevalence in acute viral hepatitis in a developed country confirmed by a supplemental assay. J Med Virol (1996) 0.94
GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic hepatitis B, C, and D. Gastroenterology (1997) 0.94
IgM antibody to hepatitis C virus in acute and chronic hepatitis C. Hepatology (1991) 0.93
Positive and negative hepatitis C virus RNA strands in serum, liver and peripheral blood mononuclear cells in anti-HCV patients: relation with the liver lesion. J Hepatol (1994) 0.93
[Guidelines on hemodialysis-associated viral infections]. Nefrologia (2004) 0.93
Irisin: 'fat' or artefact. Clin Endocrinol (Oxf) (2014) 0.93
Ultrastructure of a fibroxanthosarcoma (malignant fibroxanthoma). Cancer (1971) 0.93
Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon. Liver (1987) 0.92
Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B. Hepatology (1999) 0.92
Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy. J Hepatol (1992) 0.91
Fluorescent "in situ" hybridization of hepatitis C virus RNA in peripheral blood mononuclear cells from patients with chronic hepatitis C. J Med Virol (2000) 0.91
Immuno-electron microscopic localization of a choriogonadotropin-like antigen in cancer-associated bacteria. Oncology (1979) 0.91
Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int (1998) 0.91
A cellular and malignant blue nevus: a light and electron microscopic study. Cancer (1969) 0.91
Concentrated ascitic fluid reinfusion in cirrhotic patients: a simplified method. Am J Kidney Dis (1997) 0.91
Ornithine decarboxylase in developing rat heart and brain: role of sympathetic development for responses to autonomic stimulants and the effects of reserpine on maturation. J Pharmacol Exp Ther (1977) 0.90
Distribution of hepatitis C virus infection in liver biopsies from children and adults with chronic hepatitis C. J Med Virol (2001) 0.90
Ultrastructure of a cardiac myxoma. Arch Pathol (1969) 0.90
Induction of interleukin-12 production in chronic hepatitis C virus infection correlates with the hepatocellular damage. J Infect Dis (1998) 0.89
Comparison of several PCR procedures for detection of serum HCV-RNA using different regions of the HCV genome. J Virol Methods (1992) 0.89
Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha. Dig Dis Sci (1994) 0.89
Serological and histological follow up of chronic hepatitis B infection. Arch Dis Child (1989) 0.88
Factors predictive of response to interferon therapy in children with chronic hepatitis B. J Hepatol (1995) 0.88
High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial. Hepatology (1991) 0.87
Concordance of hepatitis C virus typing methods based on restriction fragment length polymorphism analysis in 5' noncoding region and NS4 serotyping, but not in core PCR or a line probe assay. J Clin Microbiol (1997) 0.87
Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection. J Virol (2005) 0.86